Company profile
PepGene
DEVELOP LIFE-CHANGING THERAPEUTICS FOR CANCER
- Industry
- Biotechnology Research
- Employees
- 2
- Headquarters
- Cambridge, MA
- Founded
- 2019
- LinkedIn followers
- 349
- Office locations
- 1
PepGene company summary
PepGene is a company in the Biotechnology Research industry, headquartered in Cambridge, MA, founded in 2019. On LinkedIn the company has around 2 employees and 349 followers. Its listed specialties include immune-oncology, cancer vaccine, bioinformatics, artificial intelligence, drug delivery technology.
What technology does PepGene use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About PepGene
PepGene is an immune-oncology (IO) company that operates in both the US and China. PepGene utilizes novel computational algorithms and drug delivery technology to create neoantigen-based therapeutics which empower human immune system to efficiently eradicate cancer. PepGene is motivated by a wild range of unmet medical needs in the oncology field. Although existing target and immune-oncology therapies have significantly improved the clinical outcome, the majority of cancer patients do not respond to any types of clinical IO treatments or combinations. Thus, new targets and novel therapies are desperately needed. Inspired by the uniqueness of the profile of tumor-specific antigens, also termed as neoantigens, in individual patients, we aim at building a truly personalized IO therapeutic strategy that potently and safely targets and eliminates cancer.
Specialties
Where is PepGene located?
PepGene lists 1 location.
Compare companies similar to PepGene
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
PepGene pepgenebio.com | Biotechnology Research | 2 | 2019 | Cambridge, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about PepGene
What does PepGene do?
PepGene is an immune-oncology (IO) company that operates in both the US and China. PepGene utilizes novel computational algorithms and drug delivery technology to create neoantigen-based therapeutics which empower human immune system to efficiently eradicate cancer. PepGene is motivated by a wild range of unmet medical needs in the oncology field. Although existing target and immune-oncology therapies have significantly improved the clinical outcome, the majority of cancer patients do not respond to any types of clinical IO treatments or combinations. Thus, new targets and novel therapies are desperately needed. Inspired by the uniqueness of the profile of tumor-specific antigens, also termed as neoantigens, in individual patients, we aim at building a truly personalized IO therapeutic strategy that potently and safely targets and eliminates cancer.
How many employees does PepGene have?
PepGene has around 2 employees on LinkedIn.
Where is PepGene headquartered?
PepGene is headquartered in Cambridge, MA.
When was PepGene founded?
PepGene was founded in 2019.
Build a lead list from companies like PepGene
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.